Feng Zhang.
Co-founder of CRISPR genome editing
He advanced CRISPR for use in human cells. His work pushed gene editing into medicine.
In 1981, he was born in China.
In 2009, he completed his PhD in Chemistry at Stanford University.
In 2013, he helped develop CRISPR for use in mammalian cells.
1. CRISPR genome editing, a tool that cuts and edits DNA inside human cells.
2. It supports research on genetic and neurological diseases.
3. He co-founded Editas Medicine in 2013.
His research accelerated clinical gene-editing studies.
His work influenced modern biomedical science.
He currently leads research at the Broad Institute of MIT and Harvard.
Want to know more stories? Visit Feng Zhang.